Close Close
Popular Financial Topics Discover relevant content from across the suite of ALM legal publications From the Industry More content from ThinkAdvisor and select sponsors Investment Advisor Issue Gallery Read digital editions of Investment Advisor Magazine Tax Facts Get clear, current, and reliable answers to pressing tax questions
Luminaries Awards
ThinkAdvisor

Life Health > Health Insurance > Health Insurance

Benefitfocus surges most since 2013 on Marsh & McLennan deal

X
Your article was successfully shared with the contacts you provided.

(Bloomberg) — Benefitfocus Inc., (Nasdaq:BNFT) the provider of software that helps employers offer insurance options to their staff, jumped the most since 2013 after Marsh & McLennan Cos. (NYSE:MMC) announced a deal to invest in the company.

Mercer, a consulting unit at New York-based Marsh & McLennan, acquired a 9.9 percent stake in the software seller, Benefitfocus Chief Executive Officer Shawn Jenkins said late Tuesday in a conference call. Benefitfocus rose 50 percent to 34.34 at 9:33 a.m. in New York Wednesday.

The deal will allow Mercer to expand its insurance exchange, which uses Benefitfocus’s technology to provide benefits such as life and disability coverage. Mercer’s investment injects $74.7 million in cash to fund the software provider’s growth, Benefitfocus Chief Financial Officer Milton Alpern said on the conference call.

See also: Exchange wants ancillary product partners.

“The success of Mercer Marketplace is driven by the flexibility that allows it to meet the needs of a wide range of companies and individuals,” Mercer CEO Julio Portalatin said Tuesday in a statement. “Our proprietary solution – powered by Benefitfocus technology – is critical to that flexibility as we continue to innovate.”

Mercer paid $26.50 a share and has the right to buy an additional 2 percent of the company’s stock over the next 30 months at the same price, Alpern said. The software company hasn’t been profitable since its initial public offering in 2013, when it raised about $130.8 million at $26.50 a share.

Marsh & McLennan slipped 3 cents to $57.44.


NOT FOR REPRINT

© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.